Stay updated on Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.4.3, was added and the previous Revision: v3.4.2 entry was removed.
    Difference
    0.0%
    Check dated 2026-03-06T21:00:32.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T12:14:03.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-05T14:22:28.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    UI updates include a glossary toggle, color-coded highlights for additions and deletions, and a revision banner showing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-29T06:27:29.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4 in the page footer, with no changes to study data or record content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:08:02.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-17T18:51:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.